QSP modeling of a transiently inactivating antibody-drug conjugate highlights benefit of short antibody half life by Khera, Eshita, Dharmarajan, Lekshmi, Hainzl, Dominik, Engelhardt, Volker, Vostiarova, Helena, Davis, John, Ebel, Nicolas, Wuersch, Kuno, Romanet, Vincent, Sharaby, Sherif, Kearns, Jeffrey D.

Get full text

S227928: A Novel Anti-CD74 ADC with MCL-1 Inhibitor Payload for the Treatment of Acute Myeloid Leukemia (AML) and Other Hematologic Malignancies by Maragno, Ana-Leticia, Seiss, Katherine, Newcombe, Rick, Mistry, Prakash, Schnell, Christian R, Von Arx, Fabian, Koenig, Julie, Malamas, Anthony S, Le Toumelin-Braizat, Gaetane, Bresson, Laura, Rocchetti, Francesca, Demarles, Didier, Kurth, Esther, Renteria, Lorena, Hainzl, Dominik, Engelhardt, Volker, Liot, Caroline, Madelain, Vincent, Kostova, Vesela, Starck, Jérôme-Benoit, Valour, Damien, Franzetti, Georges-Alain, Colland, Frederic, Vostiarova, Helena, Tschantz, William R, Bachmann, Nicholas, Palacio-Ramirez, Sebastian, Burger, Matthew T, Campbell, Jennifer M, Chen, Zhuoliang, Koenig, Robert, McNeill, Eric, Mo, Ruowei, Nakajima, Katsumasa, Palermo, Mark G, Shen, Yiping, Yu, Bing, Zambrowski, Mark, Zhang, Alan, Zecri, Frederic, Broniscer, Alberto, Geneste, Olivier, Horton, Kristin, D'Alessio, Joseph A

Get full text